Nembutal, the commercial name for pentobarbital sodium, is a high-potency short-acting barbiturate that has been a cornerstone of clinical sedation and emergency medicine for nearly a century. While its use in routine insomnia treatment has largely been supplanted by modern benzodiazepines, its role in critical care, neurology, and end-of-life medicine remains irreplaceable. Understanding the nuances […]